ZIELGERICHTETE SPEZIFISCHE ANTIKÖRPER-SUPERANTIGEN KONJUGATE UND IHRE PRÄPARATION
A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KERBLOM, EVA, S-752 52 UPPSALA, SE KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE DOHLSTEN, MIKAEL, S-223 52 LUND, SE LANDO, PETER, S-214 34 MALMOE, SE HEDLUND, GUNNAR, S-223 51 LUND, SE |
| description | A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a method for the lysis of target cells, wherein the target cells are contacted with a target cell lysis effective amount of the conjugate. The method of lysis is part of a potent treatment regimen for cancer, autoimmunity, parasitic infestations and fungal, viral and bacterial infections. The specification also describes modes such as the synthesis of the conjugate and pharmaceutical compositions and their manufacture. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE69122777TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE69122777TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE69122777TT23</originalsourceid><addsrcrecordid>eNrjZAiO8nT1cXcN8nT2CHENcVUIDnCN8nTzDHb2cFVw9Avx9D48LSjANUg3OBRIggTcXf0UvP39vELdHYHKQ_1cFDw9glwVAoIOtwQ4BjmGePr78TCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeBdXM0tDIyNzc_OQECNjohQBAIQHMu4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ZIELGERICHTETE SPEZIFISCHE ANTIKÖRPER-SUPERANTIGEN KONJUGATE UND IHRE PRÄPARATION</title><source>esp@cenet</source><creator>KERBLOM, EVA, S-752 52 UPPSALA, SE ; KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE ; DOHLSTEN, MIKAEL, S-223 52 LUND, SE ; LANDO, PETER, S-214 34 MALMOE, SE ; HEDLUND, GUNNAR, S-223 51 LUND, SE</creator><creatorcontrib>KERBLOM, EVA, S-752 52 UPPSALA, SE ; KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE ; DOHLSTEN, MIKAEL, S-223 52 LUND, SE ; LANDO, PETER, S-214 34 MALMOE, SE ; HEDLUND, GUNNAR, S-223 51 LUND, SE</creatorcontrib><description>A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a method for the lysis of target cells, wherein the target cells are contacted with a target cell lysis effective amount of the conjugate. The method of lysis is part of a potent treatment regimen for cancer, autoimmunity, parasitic infestations and fungal, viral and bacterial infections. The specification also describes modes such as the synthesis of the conjugate and pharmaceutical compositions and their manufacture.</description><edition>6</edition><language>ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1997</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19970410&DB=EPODOC&CC=DE&NR=69122777T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19970410&DB=EPODOC&CC=DE&NR=69122777T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KERBLOM, EVA, S-752 52 UPPSALA, SE</creatorcontrib><creatorcontrib>KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE</creatorcontrib><creatorcontrib>DOHLSTEN, MIKAEL, S-223 52 LUND, SE</creatorcontrib><creatorcontrib>LANDO, PETER, S-214 34 MALMOE, SE</creatorcontrib><creatorcontrib>HEDLUND, GUNNAR, S-223 51 LUND, SE</creatorcontrib><title>ZIELGERICHTETE SPEZIFISCHE ANTIKÖRPER-SUPERANTIGEN KONJUGATE UND IHRE PRÄPARATION</title><description>A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a method for the lysis of target cells, wherein the target cells are contacted with a target cell lysis effective amount of the conjugate. The method of lysis is part of a potent treatment regimen for cancer, autoimmunity, parasitic infestations and fungal, viral and bacterial infections. The specification also describes modes such as the synthesis of the conjugate and pharmaceutical compositions and their manufacture.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1997</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAiO8nT1cXcN8nT2CHENcVUIDnCN8nTzDHb2cFVw9Avx9D48LSjANUg3OBRIggTcXf0UvP39vELdHYHKQ_1cFDw9glwVAoIOtwQ4BjmGePr78TCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeBdXM0tDIyNzc_OQECNjohQBAIQHMu4</recordid><startdate>19970410</startdate><enddate>19970410</enddate><creator>KERBLOM, EVA, S-752 52 UPPSALA, SE</creator><creator>KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE</creator><creator>DOHLSTEN, MIKAEL, S-223 52 LUND, SE</creator><creator>LANDO, PETER, S-214 34 MALMOE, SE</creator><creator>HEDLUND, GUNNAR, S-223 51 LUND, SE</creator><scope>EVB</scope></search><sort><creationdate>19970410</creationdate><title>ZIELGERICHTETE SPEZIFISCHE ANTIKÖRPER-SUPERANTIGEN KONJUGATE UND IHRE PRÄPARATION</title><author>KERBLOM, EVA, S-752 52 UPPSALA, SE ; KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE ; DOHLSTEN, MIKAEL, S-223 52 LUND, SE ; LANDO, PETER, S-214 34 MALMOE, SE ; HEDLUND, GUNNAR, S-223 51 LUND, SE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE69122777TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1997</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KERBLOM, EVA, S-752 52 UPPSALA, SE</creatorcontrib><creatorcontrib>KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE</creatorcontrib><creatorcontrib>DOHLSTEN, MIKAEL, S-223 52 LUND, SE</creatorcontrib><creatorcontrib>LANDO, PETER, S-214 34 MALMOE, SE</creatorcontrib><creatorcontrib>HEDLUND, GUNNAR, S-223 51 LUND, SE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KERBLOM, EVA, S-752 52 UPPSALA, SE</au><au>KALLAND, TERJE, S-240 21 LOEDDEKOEPING, SE</au><au>DOHLSTEN, MIKAEL, S-223 52 LUND, SE</au><au>LANDO, PETER, S-214 34 MALMOE, SE</au><au>HEDLUND, GUNNAR, S-223 51 LUND, SE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ZIELGERICHTETE SPEZIFISCHE ANTIKÖRPER-SUPERANTIGEN KONJUGATE UND IHRE PRÄPARATION</title><date>1997-04-10</date><risdate>1997</risdate><abstract>A soluble antibody conjugate comprising an antibody linked to a structure which is recognizable by T-cells and has the ability to direct T-cells to lyse the target cell, which is recognized by the antibody. The conjugate is characterized by the structure being a superantigen. One important mode is a method for the lysis of target cells, wherein the target cells are contacted with a target cell lysis effective amount of the conjugate. The method of lysis is part of a potent treatment regimen for cancer, autoimmunity, parasitic infestations and fungal, viral and bacterial infections. The specification also describes modes such as the synthesis of the conjugate and pharmaceutical compositions and their manufacture.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_DE69122777TT2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ZIELGERICHTETE SPEZIFISCHE ANTIKÖRPER-SUPERANTIGEN KONJUGATE UND IHRE PRÄPARATION |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A01%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KERBLOM,%20EVA,%20S-752%2052%20UPPSALA,%20SE&rft.date=1997-04-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE69122777TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |